• Research Frontiers Reports 2024 Financial Results and Will Host a Conference Call at 4:30p.m. Today

    Source: Nasdaq GlobeNewswire / 06 Mar 2025 16:01:00   America/New_York

    WOODBURY, N.Y., March 06, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its fourth quarter and full-year 2024. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss its financial and operating results as well as recent developments.

     Who: Joseph M. Harary, President & CEO
     Date/Time: Thursday, March 6, 2025, 4:30 PM ET
     Dial-in Information:1-888-334-5785
     Replay: Available on Friday, March 7, 2025 for 90 days at https://smartglass-ir.com/
       

    Key Comments:

    1.Revenue Growth in the Automotive and Aircraft Markets

    Research Frontiers royalty income increased by 47% in 2024 to $1,335,531 compared to $909,598 in 2023. This revenue growth primarily came from double-digit percentage gains in royalties from the automotive and aircraft markets.

    2.Expansion of Product Pipeline.

    2024 marked the growth in use of SPD-SmartGlass in the Ferrari Purosangue and multiple McLaren car models, as well as the introduction towards the end of 2024 of the Cadillac Celestiq. Commercial airlines have begun to put SPD in their cabin windows, most notably in both Boeing and Airbus aircraft, as decision making has moved from the OEMs to their airline customers. The Company expects revenue in all market segments to increase as new car models, aircraft, trains, architectural, information display and other products using the Company’s SPD-SmartGlass technology are introduced into the market. The Company anticipates multiple new car models featuring SPD-SmartGlass technology in 2025 from OEMs in various regions of the world.

    3.Operational Efficiencies and Financial Stability.

    Expenses decreased by over $165,000 (-6%) in 2024 compared to 2023. As a result of these efficiencies, combined with rising revenue, this reduced the Company’s net loss to $1,311,382 ($0.04 per common share) for the year ended December 31, 2024, which was $596,982, (31%) lower than the net loss of $1,908,364 ($0.06 per common share) for the year ended December 31, 2023. The Company had cash and cash equivalents of approximately $2.0 million, and working capital of $2.5 million as of December 31, 2024. The Company has no debt and expects to have sufficient working capital for at least the next five years of operations.
      

    For more details, please see the Company’s Annual Report on Form 10-K which was filed today with the SEC, the contents of which are incorporated by reference herein.

    About Research Frontiers

    Research Frontiers (Nasdaq: REFR) is a publicly traded technology company and the developer of patented SPD-Smart light-control film technology which allows users to instantly, precisely and uniformly control the shading of glass or plastic products, either manually or automatically. Research Frontiers has licensed its smart glass technology to numerous companies that include well known chemical, material science and glass companies. Products using Research Frontiers’ smart glass technology are being used in tens of thousands of cars, aircraft, yachts, trains, homes, offices, museums and other buildings. For more information, please visit our website at www.SmartGlass.com, and on Facebook, Twitter, LinkedIn and YouTube.

    Note: From time to time Research Frontiers may issue forward-looking statements which involve risks and uncertainties. This press release contains forward-looking statements. Actual results, especially those reliant on activities by third parties, could differ and are not guaranteed. Any forward-looking statements should be considered accordingly. “SPD-Smart” and “SPD-SmartGlass” are trademarks of Research Frontiers Inc.

    CONTACT:
    Joseph M. Harary
    President and CEO
    Research Frontiers Inc.
    +1-516-364-1902
    Info@SmartGlass.com

    RESEARCH FRONTIERS INCORPORATED
    Consolidated Balance Sheets
    December 31, 2024 and 2023

      December 31, 2024  December 31, 2023 
    Assets      
    Current assets:        
    Cash and cash equivalents $1,994,186  $2,475,958 
    Royalties receivable, net of reserves of $1,253,450 in 2024 and 2023, respectively  658,213   1,003,404 
    Prepaid expenses and other current assets  93,490   96,784 
    Total current assets  2,745,889   3,576,146 
             
    Fixed assets, net  15,052   39,598 
    Operating lease ROU assets  1,222,640   178,715 
    Deposits and other assets  56,066   56,066 
    Total assets $4,039,647  $3,850,525 
             
    Liabilities and Shareholders’ Equity        
             
    Current liabilities:        
    Current portion of operating lease liability $129,875  $212,359 
    Accounts payable  85,825   50,880 
    Accrued expenses  53,327   14,192 
    Total current liabilities  269,027   277,431 
             
    Operating lease liability, net of current portion  1,166,285   55,363 
    Total liabilities  1,435,312   332,794 
             
    Shareholders’ equity:        
    Common stock, par value $0.0001 per share; authorized 100,000,000 shares, issued and outstanding 33,648,221 in 2024 and 33,509,287 in 2023  3,365   3,351 
    Additional paid-in capital  128,177,193   127,779,221 
    Accumulated deficit  (125,576,223)  (124,264,841)
    Total shareholders’ equity  2,604,335   3,517,731 
             
    Total liabilities and shareholders’ equity $4,039,647  $3,850,525 


    RESEARCH FRONTIERS INCORPORATED
    Consolidated Statements of Operations
    Years ended December 31, 2024 and 2023

      2024  2023 
           
    Fee income $1,335,531  $909,598 
             
    Operating expenses  2,207,397   2,359,634 
    Research and development  570,007   583,266 
    Total expenses  2,777,404   2,942,900 
             
    Operating loss  (1,441,873)  (2,033,302)
             
    Net investment income  95,339   124,938 
    Other income  35,152   - 
             
    Net loss $(1,311,382) $(1,908,364)
             
    Basic and diluted net loss per common share $(0.04) $(0.06)
             
    Weighted average number of common shares outstanding  33,520,904   33,453,627 


    RESEARCH FRONTIERS INCORPORATED
    Consolidated Statements of Shareholders’ Equity
    Years ended December 31, 2024 and 2023

      Common Stock  Additional
    Paid-in
      Accumulated    
      Shares  Amount  Capital  Deficit  Total 
                    
    Balance, December 31, 2022  33,150,396  $3,315  $127,150,027  $(122,356,477) $4,796,865 
    Exercise of warrants  358,891   36   484,466   -   484,502 
    Share-based compensation  -   -   144,728   -   144,728 
    Net loss  -   -   -   (1,908,364)  (1,908,364)
    Balance, December 31, 2023  33,509,287   3,351   127,779,221   (124,264,841)  3,517,731 
                         
    Exercise of options  8,500   1   8,669   -   8,670 
    Share-based compensation  -   -   89,316   -   89,316 
    Issuance of common stock and warrants  130,434   13   299,987   -   300,000 
    Net loss  -   -   -   (1,311,382)  (1,311,382)
    Balance, December 31, 2024  33,648,221  $3,365  $128,177,193  $(125,576,223) $2,604,335 


    RESEARCH FRONTIERS INCORPORATED
    Consolidated Statements of Cash Flows
    Years ended December 31, 2024 and 2023

      2024  2023 
    Cash flows from operating activities:        
    Net loss $(1,311,382) $(1,908,364)
    Adjustments to reconcile net loss to net cash used in operating activities:        
    Depreciation and amortization  26,169   27,348 
    Realized gain on marketable securities  -   (57,149)
    Share-based compensation  89,316   144,728 
    Credit loss expense  25,001   95,000 
    ROU asset amortization  237,394   144,794 
    Change in assets and liabilities:        
    Royalty receivables  320,190   (508,805)
    Prepaid expenses and other assets  3,294   4,189 
    Accounts payable and accrued expenses  74,080   (40,386)
    Operating lease liability  (252,881)  (196,406)
    Net cash used in operating activities  (788,819)  (2,295,051)
             
    Cash flows from investing activities:        
    Purchases of fixed assets  (1,623)  (1,558)
    Purchases of marketable securities  -   (5,434,386)
    Sales and maturities of marketable securities  -   5,491,535 
    Net cash (used in) provided by investing activities  (1,623)  55,591 
             
    Cash flows from financing activities:        
    Net proceeds from exercise of options and warrants  8,670   484,502 
    Proceeds from issuance of common stock and warrants  300,000   - 
    Net cash provided by financing activities  308,670   484,502 
             
    Net decrease in cash and cash equivalents  (481,772)  (1,754,958)
             
    Cash and cash equivalents at beginning of year  2,475,958   4,230,916 
    Cash and cash equivalents at end of year $1,994,186  $2,475,958 
             
    Supplemental disclosure of noncash items:        
    Operating lease assets obtained for operating lease liabilities $1,281,319  $- 

    Primary Logo

Share on,